良性前列腺增生手术治疗方式的研究进展
Journal: Basic Medical Theory Research DOI: 10.12238/bmtr.v6i5.10098
Abstract
近年来我国良性前列腺增生(benign prostatic hyperplasia,BPH)患病率呈上升趋势,并且有越来越年轻化的趋势。目前手术治疗仍然是BPH的主要治疗手段。其中以经尿道前列腺电切术(trasurethral resection of the prostate,TURP)为主要的手术治疗方式。随着现代医疗需求的不断增加,各种医疗技术也在不断进步,离子双极和激光等技术也不断在BPH的手术中得到应用,并且在术后疗效和并发症方面取得了显著成效。本文就BPH的各种手术方式进展进行综述。
Keywords
良性前列腺增生；激光汽化；手术方式
Full Text
PDF - Viewed/Downloaded: 0 TimesReferences
[1] Bushman W.Etiology, epidemiology, and natural history of benign prostatic hyperplasia. The Urologic Clinics of North America,2009,36(4):403-415.
[2] Braun M, Mathers M, Bondarenko B, et al. Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA). Review of the literature and six years of clinical experience[J].Urol Int.2004;72(1):32-9.
[3] Gu F L,Xia T L,Kong X T.Preliminary study of the freque ncy of benign prostatic hyperplasia and prostatic cancer in China.Urology,1994,44(5):688-691.
[4] 刘俊含,闫论,施红,等.老年群体共存疾病的现况调查.保健医学研究与实践,2017,14(06):39-42.
[5] Homma Y, Kawabe K, Tsukamoto T, et al. Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score. Internation al Journal of Urology: Official Journal of the Japanese Urolo gical Association,1997,4(1):40-46.
[6] Braun M, Mathers M, Bondarenko B, et al. Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA). Review of the literature and six years of clinical experience[J].Urol Int.2004;72(1):32-9.
[7] Zimmern P. Medical treatment modalities for lower urinary tract symptoms: what are the relevant differences in randomised controlled trials?[J]Eur Urol.2000;38 Suppl 1:18-24.
[8] 刘路,程帆,余伟民,等.良性前列腺增生症的微创治疗进展[J].武汉大学学报(医学版),2022,43(02):332-337.
[9] WongT,Tembelis M, Acharya V, et al. Prostatic Artery Embolization and Sexual Function: Literature Review and Comparison to Other Urologic Interventions[J].Tech Vasc Inte rv Radiol.2020 Sep;23(3):100693.
[10] Knight GM, Talwar A, Salem R, et al. Systematic Review and Meta-analysis Comparing Prostatic Artery Embolization to Gold-Standard Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia[J]. Cardiovasc Intervent Radiol. 2021Feb;44(2):183-193.
[11] Abt D, Hechelhammer L, Müllhaupt G, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyper plasia: randomised, open label, non-inferiority trial[J]. BMJ. 2018 Jun19;361:k2338.
[12] Richardson AJ, Acharya V, Kably I, et al. ProstaticArtery Embolization: Variant Origins and Collaterals[J]. Tech Vasc Interv Radiol.2020 Sep;23(3):100690.
[13] Wong T, Tembelis M, Acharya V, et al. Prostatic Artery Embolization and Sexual Function: Literature Review and Comparison to Other Urologic Interventions[J]. Tech Vasc Inte rv Radiol. 2020 Sep;23(3):100693.
[14] Bagla S, Smirniotopoulos J, Orlando J, et al. Cost Analysis of Prostate Artery Embolization (PAE) and Transure thral Resection of the Prostate (TURP) in the Treatment of Benign Prostatic Hyperplasia[J]. Cardiovasc Intervent Radiol. 2017 Nov;40(11):1694-1697.
[15] Xu XJ, Li J, Huang XZ, et al. An updated meta-analysis of prostatic arterial embolization versus transurethral rese ction of the prostate in the treatment of benign prostatic hyperplasia[J].World J Urol.2020 Oct;38(10):2455-2468.
[16] Law YXT, Chen WJK, Shen L, et al. Is transurethral needle ablation of prostate out of fashion? Outcomes of single session office-based transurethral needle ablation of prostate in patients with symptomatic benign prostatic hyperplasia[J].Investig Clin Urol.2019 Sep;60(5):351-358.
[17] Zlotta AR, Giannakopoulos X, Maehlum O, et al. Longterm evaluation of transurethral needle ablation of the prost ate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers[J].Eur Urol.2003 Jul;44(1):89-93.
[18] Hill B, Belville W, Bruskewitz R, et al. Transurethral needle ablation versus transurethral resection of the prosta te for the treatment of symptomatic benign prostatic hyperp lasia:5-year results of a prospective, randomized, multicen ter clinical trial[J]. J Urol. 2004 Jun;171(6 Pt 1):2336-40.
[19] Dixon CM, Cedano ER, Pacik D, et al. Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia[J]. Res Rep Urol. 2016 Nov 21;8:207-216.
[20] McVary KT, Gange SN, Gittelman MC, et al. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia[J].J Urol.2016May;195(5):1529-1538.
[21] 刘甜甜,康健,李杜渐,等.经尿道柱状水囊前列腺扩裂术的疗效分析[J].临床泌尿外科杂志,2022,37(06):470-473.
[22] 贾斌,付凤林,周玉石,等.经尿道柱状水囊前列腺扩开术治疗良性前列腺增生30例[J].中国微创外科杂志,2019,19(04):319-321.
[23] ZhongJ,FengZ,PengY,etal.ASystematic Review and Meta -analysis of Efficacy and Safety Following Holmium Laser Enucleation of Prostate and Transurethral Resection of Prostate for Benign Prostatic Hyperplasia[J]. Urology.2019 Sep;131:14-20.
[24] DasAK,HanTM,HardackerTJ. Holmium laser enucleation of the prostate (HoLEP): size-independent gold standard for surgical management of benign prostatic hyperplasia[J]. Can J Urol.2020 Aug;27(S3):44-50.
[25] Bebi C,Turetti M,Lievore E,etal.Sexual and ejaculato ry function after holmium laser enucleation of the prostate and bipolar transurethral enucleation of the prostate: a single-center experience[J].Int J Impot Res. 2022 Jan;34(1): 71-80.
[26] DeCao H, Wang J, Huang Y, et al. Comparison between thulium laser resection of prostate and transurethral plasma kinetic resection of prostate or transurethral resection of prostate[J].Sci Rep.2015 Oct 7;5:14542.
[27] Bach T, Muschter R, Sroka R, et al. Laser treatment of benign prostatic obstruction: basics and physical differences [J].Eur Urol.2012 Feb;61(2):317-25.
[28] Carmignani L,Bozzini G,Macchi A,et al. Sexual outcome of patients undergoing thulium laser enucleation of the prostate for benign prostatic hyperplasia[J]. Asian J Androl. 2015Sep-Oct;17(5):802-6.
[29] Xiao KW, Zhou L,He Q,et al. Enucleation of the prostate for benign prostatic hyperplasia thulium laser versus holmium laser: a systematic review and meta-analysis[J]. Lasers Med Sci.2019 Jun;34(4):815-826.
[30] Eken A,Soyupak B.Safety and efficacy of photoselect ive vaporization of the prostate using the 180-W GreenLight XPS laser system in patients taking oral anticoagulants[J]. J Int Med Res.2018 Mar;46(3):1230-1237.
[31] Mordasini L, Di Bona C, Klein J, et al. 80-W GreenLight Laser Vaporization Versus Transurethral Resection of the Pros tate for Treatment of Benign Prostatic Obstruction: 5-Year Outcomes of a Single-center Prospective Randomized Trial[J]. Urology.2018Jun;116:144-149.
[32] 宋文,王涛,凌青,等.铥激光前列腺汽化切除术与传统经尿道前列腺电切术疗效比较及术后尿道狭窄相关因素分析[J].中华男科学杂志,2017,23(12):1085-1088.
[2] Braun M, Mathers M, Bondarenko B, et al. Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA). Review of the literature and six years of clinical experience[J].Urol Int.2004;72(1):32-9.
[3] Gu F L,Xia T L,Kong X T.Preliminary study of the freque ncy of benign prostatic hyperplasia and prostatic cancer in China.Urology,1994,44(5):688-691.
[4] 刘俊含,闫论,施红,等.老年群体共存疾病的现况调查.保健医学研究与实践,2017,14(06):39-42.
[5] Homma Y, Kawabe K, Tsukamoto T, et al. Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score. Internation al Journal of Urology: Official Journal of the Japanese Urolo gical Association,1997,4(1):40-46.
[6] Braun M, Mathers M, Bondarenko B, et al. Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA). Review of the literature and six years of clinical experience[J].Urol Int.2004;72(1):32-9.
[7] Zimmern P. Medical treatment modalities for lower urinary tract symptoms: what are the relevant differences in randomised controlled trials?[J]Eur Urol.2000;38 Suppl 1:18-24.
[8] 刘路,程帆,余伟民,等.良性前列腺增生症的微创治疗进展[J].武汉大学学报(医学版),2022,43(02):332-337.
[9] WongT,Tembelis M, Acharya V, et al. Prostatic Artery Embolization and Sexual Function: Literature Review and Comparison to Other Urologic Interventions[J].Tech Vasc Inte rv Radiol.2020 Sep;23(3):100693.
[10] Knight GM, Talwar A, Salem R, et al. Systematic Review and Meta-analysis Comparing Prostatic Artery Embolization to Gold-Standard Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia[J]. Cardiovasc Intervent Radiol. 2021Feb;44(2):183-193.
[11] Abt D, Hechelhammer L, Müllhaupt G, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyper plasia: randomised, open label, non-inferiority trial[J]. BMJ. 2018 Jun19;361:k2338.
[12] Richardson AJ, Acharya V, Kably I, et al. ProstaticArtery Embolization: Variant Origins and Collaterals[J]. Tech Vasc Interv Radiol.2020 Sep;23(3):100690.
[13] Wong T, Tembelis M, Acharya V, et al. Prostatic Artery Embolization and Sexual Function: Literature Review and Comparison to Other Urologic Interventions[J]. Tech Vasc Inte rv Radiol. 2020 Sep;23(3):100693.
[14] Bagla S, Smirniotopoulos J, Orlando J, et al. Cost Analysis of Prostate Artery Embolization (PAE) and Transure thral Resection of the Prostate (TURP) in the Treatment of Benign Prostatic Hyperplasia[J]. Cardiovasc Intervent Radiol. 2017 Nov;40(11):1694-1697.
[15] Xu XJ, Li J, Huang XZ, et al. An updated meta-analysis of prostatic arterial embolization versus transurethral rese ction of the prostate in the treatment of benign prostatic hyperplasia[J].World J Urol.2020 Oct;38(10):2455-2468.
[16] Law YXT, Chen WJK, Shen L, et al. Is transurethral needle ablation of prostate out of fashion? Outcomes of single session office-based transurethral needle ablation of prostate in patients with symptomatic benign prostatic hyperplasia[J].Investig Clin Urol.2019 Sep;60(5):351-358.
[17] Zlotta AR, Giannakopoulos X, Maehlum O, et al. Longterm evaluation of transurethral needle ablation of the prost ate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers[J].Eur Urol.2003 Jul;44(1):89-93.
[18] Hill B, Belville W, Bruskewitz R, et al. Transurethral needle ablation versus transurethral resection of the prosta te for the treatment of symptomatic benign prostatic hyperp lasia:5-year results of a prospective, randomized, multicen ter clinical trial[J]. J Urol. 2004 Jun;171(6 Pt 1):2336-40.
[19] Dixon CM, Cedano ER, Pacik D, et al. Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia[J]. Res Rep Urol. 2016 Nov 21;8:207-216.
[20] McVary KT, Gange SN, Gittelman MC, et al. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia[J].J Urol.2016May;195(5):1529-1538.
[21] 刘甜甜,康健,李杜渐,等.经尿道柱状水囊前列腺扩裂术的疗效分析[J].临床泌尿外科杂志,2022,37(06):470-473.
[22] 贾斌,付凤林,周玉石,等.经尿道柱状水囊前列腺扩开术治疗良性前列腺增生30例[J].中国微创外科杂志,2019,19(04):319-321.
[23] ZhongJ,FengZ,PengY,etal.ASystematic Review and Meta -analysis of Efficacy and Safety Following Holmium Laser Enucleation of Prostate and Transurethral Resection of Prostate for Benign Prostatic Hyperplasia[J]. Urology.2019 Sep;131:14-20.
[24] DasAK,HanTM,HardackerTJ. Holmium laser enucleation of the prostate (HoLEP): size-independent gold standard for surgical management of benign prostatic hyperplasia[J]. Can J Urol.2020 Aug;27(S3):44-50.
[25] Bebi C,Turetti M,Lievore E,etal.Sexual and ejaculato ry function after holmium laser enucleation of the prostate and bipolar transurethral enucleation of the prostate: a single-center experience[J].Int J Impot Res. 2022 Jan;34(1): 71-80.
[26] DeCao H, Wang J, Huang Y, et al. Comparison between thulium laser resection of prostate and transurethral plasma kinetic resection of prostate or transurethral resection of prostate[J].Sci Rep.2015 Oct 7;5:14542.
[27] Bach T, Muschter R, Sroka R, et al. Laser treatment of benign prostatic obstruction: basics and physical differences [J].Eur Urol.2012 Feb;61(2):317-25.
[28] Carmignani L,Bozzini G,Macchi A,et al. Sexual outcome of patients undergoing thulium laser enucleation of the prostate for benign prostatic hyperplasia[J]. Asian J Androl. 2015Sep-Oct;17(5):802-6.
[29] Xiao KW, Zhou L,He Q,et al. Enucleation of the prostate for benign prostatic hyperplasia thulium laser versus holmium laser: a systematic review and meta-analysis[J]. Lasers Med Sci.2019 Jun;34(4):815-826.
[30] Eken A,Soyupak B.Safety and efficacy of photoselect ive vaporization of the prostate using the 180-W GreenLight XPS laser system in patients taking oral anticoagulants[J]. J Int Med Res.2018 Mar;46(3):1230-1237.
[31] Mordasini L, Di Bona C, Klein J, et al. 80-W GreenLight Laser Vaporization Versus Transurethral Resection of the Pros tate for Treatment of Benign Prostatic Obstruction: 5-Year Outcomes of a Single-center Prospective Randomized Trial[J]. Urology.2018Jun;116:144-149.
[32] 宋文,王涛,凌青,等.铥激光前列腺汽化切除术与传统经尿道前列腺电切术疗效比较及术后尿道狭窄相关因素分析[J].中华男科学杂志,2017,23(12):1085-1088.
Copyright © 2024 魏征, 陈国俊
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
